Co-Authors
This is a "connection" page, showing publications co-authored by Debra Ritzwoller and Douglas Corley.
Connection Strength
0.476
-
Test performance metrics for breast, cervical, colon and lung cancer screening: a systematic review. J Natl Cancer Inst. 2023 Feb 08.
Score: 0.225
-
Evaluation of Harms Reporting in U.S. Cancer Screening Guidelines. Ann Intern Med. 2022 11; 175(11):1582-1590.
Score: 0.055
-
Evaluating and Improving Cancer Screening Process Quality in a Multilevel Context: The PROSPR II Consortium Design and Research Agenda. Cancer Epidemiol Biomarkers Prev. 2022 08 02; 31(8):1521-1531.
Score: 0.054
-
Cancer screening in the U.S. through the COVID-19 pandemic, recovery, and beyond. Prev Med. 2021 10; 151:106595.
Score: 0.050
-
Cancer Screening During the Coronavirus Disease-2019 Pandemic: A Perspective From the National Cancer Institute's PROSPR Consortium. Gastroenterology. 2021 03; 160(4):999-1002.
Score: 0.048
-
Collaborating on Data, Science, and Infrastructure: The 20-Year Journey of the Cancer Research Network. EGEMS (Wash DC). 2019 Mar 29; 7(1):7.
Score: 0.043